GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofarm SA (BSE:BIO) » Definitions » EV-to-FCF

Biofarm (BSE:BIO) EV-to-FCF : 22.59 (As of Mar. 26, 2025)


View and export this data going back to 1996. Start your Free Trial

What is Biofarm EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Biofarm's Enterprise Value is lei551.2 Mil. Biofarm's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was lei24.4 Mil. Therefore, Biofarm's EV-to-FCF for today is 22.59.

The historical rank and industry rank for Biofarm's EV-to-FCF or its related term are showing as below:

BSE:BIO' s EV-to-FCF Range Over the Past 10 Years
Min: -521.37   Med: 19.98   Max: 101.35
Current: 22.83

During the past 13 years, the highest EV-to-FCF of Biofarm was 101.35. The lowest was -521.37. And the median was 19.98.

BSE:BIO's EV-to-FCF is ranked better than
51.28% of 548 companies
in the Drug Manufacturers industry
Industry Median: 23.42 vs BSE:BIO: 22.83

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-26), Biofarm's stock price is lei0.684. Biofarm's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was lei0.076. Therefore, Biofarm's PE Ratio (TTM) for today is 9.00.


Biofarm EV-to-FCF Historical Data

The historical data trend for Biofarm's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofarm EV-to-FCF Chart

Biofarm Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.86 15.05 -471.79 14.03 -

Biofarm Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.03 100.78 18.51 26.67 -

Competitive Comparison of Biofarm's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Biofarm's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofarm's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofarm's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Biofarm's EV-to-FCF falls into.


';

Biofarm EV-to-FCF Calculation

Biofarm's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=551.160/24.396
=22.59

Biofarm's current Enterprise Value is lei551.2 Mil.
Biofarm's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was lei24.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biofarm  (BSE:BIO) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Biofarm's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.684/0.076
=9.00

Biofarm's share price for today is lei0.684.
Biofarm's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was lei0.076.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Biofarm EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Biofarm's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Biofarm Business Description

Traded in Other Exchanges
N/A
Address
99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.